TROG Cancer Research

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

” New in Journal of Clinical Oncology – ROBOMET
SABR vs standard radiotherapy for painful bone mets.
  • Pain relief at 1 month:
  • SABR (20 Gy single dose): 37% complete response
  • versus (8 Gy): 25% complete response
  • at 3-months withSABR: 54% vs 31%, p= .048″

Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

Authors: Carole Mercier, Charlotte Billiet, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix

You can read the Full Article on Journal of Clinical Oncology

Shankar Siva

More posts featuring Shankar Siva.